Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPFF use to improve outcomes of sclerotherapy for lower-limb varicose veins
RBR-103p86cvPhase 4Completed
- Sponsor
- Medcog
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of micronized purified flavonoid fraction and 10XB101 in Varicose veins of lower extremities (VVLE) (2 arms), sponsored by Medcog. Primary endpoints: Presence of hyperpigmentation and Presence of matting. Started May 2023; status: completed.
02
Drugs
micronized purified flavonoid fraction10XB101
03
Conditions
Varicose veins of lower extremities (VVLE)
Beyond the preview
Go deeper on RBR-103p86cv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-103p86cv.